Randstad (RAND) Q3 2024 earnings summary

Executive summary

• Q3 2024 was marked by operational discipline, strategic investments, and stabilization in several markets despite challenging macroeconomic conditions.

• Revenue reached €6.0 billion, down 5.9% year-over-year, with underlying EBITA/EBITDA at €196 million and a 3.3% margin.

• Net income was €106 million, down 38% year-over-year; adjusted net income was €124 million.

• Strategic moves included the acquisition of Zorgwerk, a leading Dutch healthcare digital marketplace, and the merger of Monster with CareerBuilder.

• Focus remained on cost control, field capacity management, and growth through specialization and digital marketplaces.

Financial highlights

• Revenue declined 5.9% year-over-year to €6.0 billion, with gross margin at 19.5%, down from 20.6% last year.

• Underlying EBITA/EBITDA was €196 million (3.3% margin), down 28% year-over-year but stable sequentially.

• Free cash flow was €258 million, with DSO at 54.1 days and net debt at €804 million; leverage ratio at 0.9.

• Operating expenses decreased 3% year-over-year; FTEs down 4% YoY (excluding Monster).

• Net income was €106 million, adjusted net income €124 million, both down from Q3 2023.

Outlook and guidance

• Q4 2024 expected to show stable trends with slightly better profitability and gross margin, aided by easier comparables and 1.1 additional working days.

• Operating expenses projected to remain broadly stable sequentially, with a €35–40 million reduction from Monster disposal.

• Monster disposal to impact Q4 gross margin by 50bps.

• Management expects a similar quarter to Q3, with a notch better profitability.